Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Mitochondria generate cellular energy (ATP) via oxidative phosphorylation (OXPHOS).
• Alterations in mitochondrial DNA (mtDNA) and respiratory activity are frequently observed in malignant cells.
• Previous studies have reported somatic mtDNA mutations and inherited mtDNA polymorphisms in various cancers.

Purpose of the Study:

• To critically evaluate the methodological and conceptual errors in current literature on mtDNA in cancer.
• To identify reasons for noise and bias in data regarding mtDNA's role in tumorigenesis.
• To propose stringent criteria and guidelines for future mtDNA research in oncology.

Main Methods:

• Review and critical reanalysis of existing literature on mtDNA mutations and polymorphisms in cancer.
• Identification and summarization of technical and conceptual flaws in published studies.
• Discussion of practical aspects and requirements for valid mtDNA analysis in clinical settings.

Main Results:

• Numerous published papers on mtDNA in cancer suffer from methodological limitations, rendering them unsuitable for systematic reviews or clinical applications.
• Common errors introduce noise and bias, complicating the interpretation of mtDNA's role in cancer development.
• Lack of stringent, case-controlled experimental designs hinders the translation of findings into clinical practice.

Conclusions:

• Despite challenges, research into mitochondrial pathophysiology in cancer remains crucial for advancing molecular medicine.
• Adherence to rigorous methodological standards is essential for generating reliable data on mtDNA in oncology.
• Future research should focus on establishing robust guidelines for mtDNA analysis to ensure clinical utility.